OncoTherapy Science, Inc. (TYO:4564)

OncoTherapy Science Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	7,910	7,606	4,353	9,054	13,292	21,689
Market Cap Growth	11.99%	74.74%	-51.92%	-31.88%	-38.71%	98.39%
Enterprise Value	5,725	6,661	3,755	8,077	11,071	18,295
Last Close Price	21.00	28.00	20.00	47.00	69.00	123.00
PS Ratio	10.09	10.14	7.14	7.98	11.53	65.33
PB Ratio	3.70	10.45	12.33	10.60	6.72	7.05
P/TBV Ratio	3.70	10.45	12.33	10.60	6.72	7.06
PEG Ratio	-	0.76	0.76	0.76	0.76	0.76
EV/Sales Ratio	7.30	8.88	6.16	7.12	9.60	55.11
Net Debt / Equity Ratio	-1.02	-1.14	-1.49	-1.31	-0.93	-0.94
Net Debt / EBITDA Ratio	-	-	-	1.02	0.90	1.82
Net Debt / FCF Ratio	-	1.02	0.43	1.40	0.73	1.61
Asset Turnover	0.42	0.74	0.51	0.54	0.38	0.08
Inventory Turnover	14.20	16.60	17.04	10.97	20.37	51.97
Quick Ratio	7.97	2.85	1.99	2.04	3.70	15.73
Current Ratio	8.53	3.38	2.28	2.34	4.31	16.46
Return on Equity (ROE)	-59.41%	-150.79%	-213.42%	-78.93%	-101.74%	-40.02%
Return on Assets (ROA)	-26.73%	-49.27%	-58.87%	-32.98%	-42.40%	-24.21%
Return on Capital Employed (ROCE)	-36.20%	-96.30%	-220.50%	-122.70%	-98.70%	-51.60%
Earnings Yield	-11.14%	-10.71%	-29.59%	-12.35%	-19.34%	-7.20%
FCF Yield	-	-10.71%	-28.23%	-8.81%	-19.03%	-8.32%
Buyback Yield / Dilution	-21.55%	-22.73%	-10.45%	-2.76%	-6.31%	-8.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.